Search hospitals > Arkansas > Little Rock

Veterans Affairs Medical Center - Little Rock (McClellan)

Claim this profile
Little Rock, Arkansas 72205
Global Leader in Lung Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
111 reported clinical trials
7 medical researchers
Photo of Veterans Affairs Medical Center - Little Rock (McClellan) in Little RockPhoto of Veterans Affairs Medical Center - Little Rock (McClellan) in Little RockPhoto of Veterans Affairs Medical Center - Little Rock (McClellan) in Little Rock

Summary

Veterans Affairs Medical Center - Little Rock (McClellan) is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Cancer, Leukemia, Lymphoma and other specialties. Veterans Affairs Medical Center - Little Rock (McClellan) is involved with conducting 111 clinical trials across 137 conditions. There are 7 research doctors associated with this hospital, such as Rangaswamy Govindarajan, Ryan Dare, MD, Matt Burns, MD, and Barry Uretsky, MD.

Area of expertise

1Lung Cancer
Global Leader
Veterans Affairs Medical Center - Little Rock (McClellan) has run 17 trials for Lung Cancer. Some of their research focus areas include:
Stage I
Stage II
Stage III
2Non-Small Cell Lung Cancer
Global Leader
Veterans Affairs Medical Center - Little Rock (McClellan) has run 13 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage I
Stage II
Stage III

Top PIs

Clinical Trials running at Veterans Affairs Medical Center - Little Rock (McClellan)

Non-Small Cell Lung Cancer
Lung Cancer
ALK Gene Rearrangement
Multiple Myeloma
Diabetic Kidney Disease
Skin Cancer
Cutaneous Melanoma
Clostridium
C. Difficile
Vancomycin
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This study is evaluating whether a drug called crizotinib may help treat patients with non-small cell lung cancer.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Ramucirumab + Pembrolizumab vs Chemotherapy

for Non-Small Cell Lung Cancer

This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out if giving ramucirumab with pembrolizumab is more effective at treating patients with stage IV or recurrent non-small cell lung cancer than standard chemotherapy.
Recruiting2 awards Phase 310 criteria
Image of trial facility.

Genetic Testing

for Early-Stage Lung Cancer

This study is evaluating whether genetic testing may help determine the best treatment for patients with lung cancer.
Recruiting0 awards N/A4 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Veterans Affairs Medical Center - Little Rock (McClellan)?
Veterans Affairs Medical Center - Little Rock (McClellan) is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Cancer, Leukemia, Lymphoma and other specialties. Veterans Affairs Medical Center - Little Rock (McClellan) is involved with conducting 111 clinical trials across 137 conditions. There are 7 research doctors associated with this hospital, such as Rangaswamy Govindarajan, Ryan Dare, MD, Matt Burns, MD, and Barry Uretsky, MD.